Amgen Inc (NAS:AMGN)
$ 308.45 -1.7 (-0.55%) Market Cap: 165.46 Bil Enterprise Value: 219.78 Bil PE Ratio: 44.06 PB Ratio: 32.94 GF Score: 89/100

Amgen Inc at Citi Global Healthcare Conference Transcript

Sep 07, 2023 / 05:00PM GMT
Release Date Price: $254.39 (+2.16%)
Juliette Lafille

Joined by Peter Griffith, CFO. Justin Claeys new Head of IR, Casey Capparelli, Executive Director of IR and the one and only Arvind Sood that everybody is known because he has been in IR for almost 2 decades.Yes?

Arvind Sood
Amgen Inc. - VP of IR

Joind back in the '20s.

Juliette Lafille

So I think maybe we'll start with some opening remarks from Amgen first.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

Thank you very much, Julia. Good afternoon, everyone, and thank you for being with us here today. As we always do at Amgen, we start with patients, and our mission to serve patients through discovering, developing, manufacturing and delivering first-in-class and best-in-class medicines to patients with grievance and serious illnesses all over the world. We're creating value for patients, staff and shareholders, and are well positioned on any number of fronts to deliver long-term growth. We're driving a successful integration beginning off of an early fourth

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot